Immuron (IMRN) Cash from Investing Activities (2016 - 2024)

Immuron (IMRN) recorded quarterly Cash from Investing Activities of $35309.1 in Q4 2024, down 64.67% quarter-over-quarter from $99932.2 in Q4 2023, and down 64.67% on a YoY basis from $99932.2 in Q1 2024.

Immuron (IMRN) Cash from Investing Activities (2016 - 2024) Analysis & Trends

Immuron's Cash from Investing Activities history runs 9 years deep, the most recent figure standing at $35309.1 for Q4 2024.

  • In Q4 2024, Cash from Investing Activities fell 64.67% year-over-year to $35309.1; the TTM figure through Dec 2024 stood at -$2.5 million (up 1.43% YoY), while the FY2025 annual figure was -$2.9 million, down 985.46% from the prior year.
  • Cash from Investing Activities was $35309.1 for Q4 2024 at Immuron, down from $99932.2 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $99932.2 in Q4 2023 to a low of -$2.6 million in Q4 2022.
  • Historically, Cash from Investing Activities has averaged -$492615.7 across 5 years, with a median of $5550.2 in 2021.
  • The sharpest annual moves came in 2021 and 2022: Cash from Investing Activities soared 1943.91% in 2021, then slumped 47009.79% in 2022.
  • A 5-year view of Cash from Investing Activities shows it stood at -$301.0 in 2020, then jumped by 1943.91% to $5550.2 in 2021, then plunged by 47009.79% to -$2.6 million in 2022, then jumped by 103.84% to $99932.2 in 2023, then slumped by 64.67% to $35309.1 in 2024.
  • The last three Cash from Investing Activities figures came in at $35309.1 (Q4 2024), $99932.2 (Q4 2023), and -$2.6 million (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Immuron 921.61 Mn 921.58 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 35,309.08
Dec 31, 2024 35,309.08
Dec 31, 2023 99,932.25
Dec 31, 2023 99,932.25
Dec 31, 2022 -2.60 Mn
Dec 31, 2022 -2.60 Mn
Dec 31, 2021 5,550.16
Dec 31, 2021 5,550.16
Dec 31, 2020 -301.00
Dec 31, 2020 -301.00
Dec 31, 2019 -605.00
Dec 31, 2019 -605.00
Dec 31, 2018 39.00
Dec 31, 2018 39.00
Dec 31, 2017 -1,698.97
Dec 31, 2017 -1,698.97
Dec 31, 2016 1,416.72
Dec 31, 2016 1,416.72